Amarin reports preliminary Q4 rev $72-74M, FY rev $304-306M; announces $50M buyback

AMARIN CORP PLCUK

2023-FY EPS reported -$0.15 revenue$306,911,000

Preliminary Q4 2023 total revenue $72-74M (Europe ~$1.5M, US $64-65M, RoW $7-8M).
Full-year 2023 revenue $304-306M; cash and investments $321M; positive cash flow ~$10M.
Plans $50M share repurchase subject to shareholder and UK High Court approval, expected by end Q2 2024.
European revenue grew ~65% QoQ; VAZKEPA now available in 9 markets; US IPE market share 57%.
Believes current cash and investments adequate to support operations including buyback; on track for $40M annual savings.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AMARIN CORP PLCUK reported fourth quarter of 2023 results: revenue $72 to $74 million.

Period: fourth quarter of 2023
Revenue: $72 to $74 million
Result: preliminary results

Exact text from the filing

For the fourth quarter, Amarin estimates total revenue between $72 to $74 million (Europe ~$1.5 million; U.S. $64 - $65 million; RoW $7 - $8 million – including supply shipments and milestone achievement)

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

AMARIN CORP PLCUK reported full year 2023 results: revenue $304 to $306 million.

Period: full year 2023
Revenue: $304 to $306 million
Result: preliminary results

Exact text from the filing

between $304 to $306 million for the full year 2023.

View on SEC.gov

Browse all earnings releases →

AMARIN CORP PLCUK filing history →

Source: SEC EDGAR

accession 0000950170-24-003511

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.